A cell-based NRG1-ERBB4 assay designed for high-throughput compound screening 
to identify small molecule modulators with relevance for schizophrenia

Hinrichs, Wilko

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2186973_2

DetailsSummary

Released

Thesis

A cell-based NRG1-ERBB4 assay designed for high-throughput compound screening to identify small molecule modulators with relevance for schizophrenia

MPS-Authors

/persons/resource/persons182199

Hinrichs, Wilko
Gene expression and signaling, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

HinrichsDiss_12.pdf
(Any fulltext), 6MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Hinrichs, W. (2012). A cell-based NRG1-ERBB4 assay designed for high-throughput compound screening to identify small molecule modulators with relevance for schizophrenia. PhD Thesis, Georg-August-Universität, Göttingen.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-5127-3

Abstract

There is no abstract available